JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 9.15
-0.20 (-2.14%)
At close: May 6, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 301.91 million as of May 7, 2026. Its market cap has decreased by -64.33% in one year.
Market Cap
301.91M
Enterprise Value
392.03M
Revenue
744.78M
Ranking
n/a
PE Ratio
11.42
Stock Price
9.15
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 301.91M, a decrease of -58.72%. That is a compound annual growth rate of -21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 301.91M | -26.80% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandu Pharmaceuticals | 415.33M |
| Panjon | 402.68M |
| ANG Lifesciences India | 402.59M |
| Murae Organisor | 353.20M |
| Walpar Nutritions | 347.45M |
| Welcure Drugs and Pharmaceuticals | 346.06M |
| Deccan Health Care | 300.08M |
| Gujarat Terce Laboratories | 293.03M |